Invited Guests
In alphabetical order
Invited Guests from overseas
Dr. Oidov BaatarkhuuProfessor of Medicine, Head of Department of Infectious Diseases, School of Medicine, Mongolian National University of Medical Sciences and General Expert on Infectious Diseases of Ministry of Health, Mongolia |
|
 |
Professor Oidov .Baatarkhuu graduated from the Mongolian National Medical University and obtained his degree in Doctor of Medicine with commendation in 1994. He has received his PhD degree at the Postgraduate School, Health Sciences University of Mongolia in 2006. He is currently Professor of Medicine, Head of Department of Infectious Diseases, School of Medicine, Mongolian National University of Medical Sciences and General Expert on Infectious |
|
Diseases of Ministry of Health, Mongolia. He has completed his postdoctoral Fellowship in Hepatology at the Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea between 2007-2008. He did second overseas Clinical Research Fellowship in Hepatology at the Department of Internal Medicine III, AKH Hospital, University of Vienna, Austria in 2012. Also currently he has completed as a Clinical Research Fellow in Hepatology at the Storr Liver unit, Westmead Millennium Institute for Medical Research, University of Sydney, Australia. He has also been a Visiting Professor at the Victorian Infectious Diseases Laboratory, Melbourne, Australia in 2014. Professor O.Baatarkhuu is an Executive Council Member of APASL, Member of CEVHAP, and President of the Mongolian Association for the Study of the Liver Diseases, Executive Director of the Mongolian Infectious Diseases Physicians, and Chairman of the Scientific Committee for the APASL-STC 2012 in Mongolia Professor O.Baatarkhuu is a key investigator in more than 10 international and national trials on antiviral treatment of chronic hepatitis B and C. He has been extensively involved in research in the fields of viral hepatitis and hepatocellular carcinoma and he is currently working on the natural history of hepatitis B and D in Mongolia. Professor O.Baatarkhuu has published more than 120 international and local papers. He also has spoken nationally and internationally on viral hepatitis and chronic liver diseases including hepatocellular carcinoma. |
|
Dr. Wan-Long ChuangProfessor, Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University, Vice Superintendent, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan |
|
 |
Educational and Career Experiences ･ MD, 1973-1980, Kaohsiung Medical University, Kaohsiung, Taiwan ･ PhD, 1988-1993, Postgraduate Institute, Kaohsiung Medical University, Taiwan ･ Associate Professor, 1993-2004, School of Medicine, Kaohsiung Medical University, Taiwan, ･ Professor, 2004- Present, School of Medicine, Kaohsiung Medical University, Taiwan, |
|
Publication More than 300 peer-review articles on viral hepatitis (particularly HBV and HCV), liver cirrhosis and hepatocellular carcinoma in Gastroenterology, Hepatology, Gut, Journal of Hepatology, etc. Awards and Honors ･ Award for Outstanding Contributions in Science and Technology, Executive Yuan, Taiwan, 2009 ･ Distinguished Research Award, National Science Council, Taiwan, 2011 |
|
Dr. A. Kadir DokmeciEmeritus Professor of Gastroenterology at the Ankara University School of Medicine, Ankara, Turkey |
|
 |
A.Kadir Dökmeci was born in 1948 at Ilgaz, Turkey. He received his medical degree from the Ankara University School of Medicine (AUSM) in 1971 and qualified as a gastroenterologist in 1978. He has studied ultrasonography, endoscopic retrograde cholangiopancreatography (ERCP) as well as clinical hepatology in the Department of Internal Medicine at the Chiba University School of Medicine in Japan as Prof. Okuda’s student from 1979 to 1981 for 2.5 years. |
|
He had worked together with Dr. Masao Omata and Dr. Osamu Yokosuka in this period. He was subsequently appointed as associate professor in 1982 and as a professor in 1988 and served as chief of Department of Internal Medicine and as a chief of Department of Gastroenterology at AUSM from 1993 to 2000. Prof. Dökmeci has been a visiting professor at the Chiba University School of Medicine from 1988 to 1989 and at the University of California, Irvine in 2003. He is founder and member of many national and international societies, including Turkish Society of Hepatobliopancreatology (serving as president), Turkish Society of Gastroenterology, and Turkish Association for the Study of the Liver, The Association of the Turkish and Japanese Universities, Turkish Society of Endoscopy, Asian Pacific Association for the Study of the Liver. He has received national and international awards in his carrier including Inohana Award given by Chiba University in 1999. He has organized many medical congresses and international Sports competitions including 5th APASL STC in İstanbul and both International Figure Skating and Ice Hockey Competitions. Also he organized the 25th APASL Annual Conference 2015 in İstanbul. He was elected as the President of APASL from 2014 to 2015. He has contributed to editorials, reviews and book chapters. He is in editorial board in various journals such as Hepatology International, Digestive Endoscopy and Turkish Journal of Gastroenterology. He was elected as a medical committee member and medical supervisor of International Ice Hockey Federation. He published more than 100 papers in different journals. A.Kadir Dökmeci is currently Emeritus Professor of Gastroenterology at the Ankara University School of Medicine and acting as the Past President of APASL. He is married and has 1 daughter. |
|
Dr. Edward John GaneHepatologist and Associate Director, New Zealand Liver Transplant Unit, Auckland, New Zealand |
|
 |
Academic Qualifications 1998 Doctor of Medicine, University of Otago. 1992 Fellow of the Royal Australasian College of Physicians. 1983 MBChB, School of Medicine, University of Otago. |
|
Professional Positions Held 2000 Nov-present: Adjunct Professor of Medicine, University of Auckland. 2011-2014: Honorary Clinical Professor of Medicine, University of Auckland. 2005-2010: Honorary Clinical Associate Professor of Medicine, University of Auckland. 2000-present: Deputy Director and Chief Hepatologist, New Zealand Liver Transplant Unit Auckland City Hospital. 1998-present: Lead Physician, National Hepatoma Service, Auckland City Hospital 2010-present: Ministry of Health Champion for Hepatitis C, Clinical Advisor to the Hepatitis C Project (2011-2015) 2007-Jan 2010: Chairman, Ministry of Health Hepatitis C Treatment Advisory Group (HCTAG). 1998-present: Clinical Advisor, National Hepatitis B Screening Programme. 1999-present: PITAC ID Advisory Committee and PHARMAC Advisor on new antivirals for HBV and HCV. 2005-present: Australasian Representative and Council Member, Asian and Pacific Association of the Study of the Liver (Elected President for 2014). 2002-present: Member and Co-Author of Consensus Committee for APASL Guidelines for the Management of chronic hepatitis C (co-authored the 2005, 2008 Consensus). 2005-present: Member and Co-Author of Consensus Committee for APASL Guidelines for the Management of chronic hepatitis B (co-authored the 2005, 2008, 2012 and 2015 Consensus documents). 2008- present Principal Investigator, Auckland Clinical Studies Early Phase Unit, ECOM House, 3 Ferncroft Street, Grafton, Auckland, New Zealand 2007-2010: Chairperson of Hepatitis C Treatment Advisory Group to the Ministry of Health 2009-2015: Executive Committee of the New Zealand Gastroenterology 2012-2015: Executive Committee of the Australasian Society of HIV and Hepatitis Medicine (ASHM). 2015-current: Ministry of Health Hepatitis C Implementation Advisory Group (Chairman) 2016-current: Northern Regional District health Board Alliance, Hepatitis C Committee (Chairman) 2005-current: Governing Board for the Hepatitis Foundation of New Zealand 2016 Oct-Jan: Visiting Faculty, Stanford University Faculty of Medicine |
|
Dr. Kwang-Hyub HanProfessor and chairman of Department of Internal Medicine, Yonsei University College of Medicine (YUMC) and director of Yonsei Liver Center, Severance Hospital, Seoul, Korea |
|
 |
He graduated YUMC in 1979. He was the director and principal investigator of a 9-year project, “Clinical Research Center for Liver Cirrhosis,” granted from the Ministry of Health and Welfare and Health Technology Planning. He is a member of The Korean Academy of Science Technology. He served as the president of Korean Association for the Study of the Liver and hosting president of Liver Week 2014 and 2015. |
|
He was also the hosting president of APASL STC 2016 in Busan. He was a founding co-chairman and hosting chairman of APPLE (Asia-Pacific Primary Liver Cancer Exert) meeting and served as the first president of APPLE association. At present, he is an executive committee member of APPLE and CEVHEP. He is also serving as an associate editor of Liver Cancer, assistant editor of Hepatology International and an editorial board member of Journal of Hepatology. He is the author of several book chapters on topics such as ‘hepatocellular carcinoma’, ‘Liver Cirrhosis, a practical guide of management’, as well as more than 400 articles. |
|
Dr. Jinlin HouDirector and Professor of the Hepatology Unit and Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China |
|
 |
Professor Jin-Lin Hou is the Director and Professor of the Hepatology Unit and Department of Infectious Diseases, Nanfang Hospital, Southern Medical University. Professor Hou joined the University Department of Medicine of Nanfang Hospital in July 1984. Between 1993 and 1994, he received training in the Department of Medicine at St. Mary’s Hospital Medical School in London, UK. Between 2000 and 2001, Professor Hou was a visiting Fellow at the Institute of Hepatology, London, UK. |
|
He has been invited to deliver talks at both national and international liver conferences owing to his expertise in viral hepatitis.
His current research interests include the clinical management of viral hepatitis and the molecular virology and immunology of hepatitis B virus (HBV) and severe acute respiratory syndrome (SARS) infection. Professor Hou has published more than 150 articles in both national and international journals, including Hepatology, Science, Journal of Immunology and Journal of Clinical Microbiology. |
|
Dr. Wasim JafriDirector, World Gastroenterology Training Center in Pakistan |
|
 |
Dr. Jafri is a very well-known Hepatologist/ Gastroenterologist in Pakistan and he has earned a great name in Pakistan and the region. After obtaining initial training in medicine and gastroenterology in the United Kingdom (UK) he was trained in Hepatology at the University of Miami, Florida working with Dr. Schiff. He introduced the art of gastroenterology and Hepatology in Pakistan when he returned back in 1987 and since then he is at the Aga Khan University in Karachi |
|
Pakistan. Dr Jafri is a Member of the Royal College of Surgeons, Member of the Royal College of Physicians United Kingdom, Fellow of the Royal Colleges of Physicians of London, Edinburgh and Glasgow, Fellow of the American College of Physicians and Fellow of the American College of Gastroenterology. He had been the Governor of the American College of Gastroenterology for Pakistan from 2012-2015. Dr Jafri is also the director of World Gastroenterology Training Center in Pakistan He had been Chair of Medicine and the Head of Gastroenterology and Hepatology and is currently heading the Department for Continuing Professional Education (DCPE) along with his clinical and other responsibilities. He has over 200 peer reviewed publications in gastroenterology and Hepatology which are referenced in national and international journals. At the AASLD he is a member since 2001 and has been supporting the special interest group of portal hypertension and fatty liver disease. He is also an active member of AGA, EASL, IASL, APASL, PSSLD, and PSG. He has been member and chair of several national and international conferences in various capacities and has been a guest faculty to several national and international meetings as a speaker /chair/moderator. His research work has been presented at the AASLD, EASL, APASL, AGA, and many other meetings in poster or oral presentations. At the national level he had been the general secretary for Pakistan Society of Gastroenterology, Vice President of Pakistan Society of Hepatology, and Founding President of Pakistan Society for the Study of Liver and is currently the Patron of that Society. At the APASL he had been the part of the executive committee and is currently on its advisory panel. His name has appeared in almost all the important guidelines of APASL which include Hepatitis B, Hepatitis C, HCC, Variceal bleed and portal hypertension and liver fibrosis. He has also been part of WHO 2014 guidelines on chronic hepatitis C. He has also contributed to the national guidelines for hepatitis B and C in Pakistan. He was assistant editor of Hepatalogy International and is currently an editorial board member of this journal. He has been editorial board member of liver International, World Journal of Gastroenterology, Translational Gastroenterology, Annals of Gastroenterology and Hepatology, Journal of Clinical and Experimental Gastroenterology, Dataset Papers in Medicine, Austin Journal of Hepatology, Pakistan Journal of Gastroenterology, Journal of Microbial and Biochemical Technology, Guest Editor of Hepatitis Research and Treatment, Journal of Dow university of Health Sciences, Journal of Liaquat University of Health science, Guest editor of International Journal of Hepatology and many more. In Pakistan he has trained scores of physicians in the field of Gastroenterology and Hepatology who themselves are now professors and heads of departments at various institutions and training others. His contributions in the field of liver diseases and gastroenterology in that part of the world is second to none. On the basis of what I personally know about him, as well as his achievements in the field of hepatology, I would most enthusiastically recommend him for the coveted position of the fellow of the AASLD as this will serve as an important recognition of his already very accomplished career. |
|
Dr. Jia-Horng KaoDirector, Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan |
|
 |
Educational and Career Experiences ･ 1980-1987 M.D. College of Medicine, National Taiwan University, Taiwan ･ 1991-1994 Ph.D. Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine ･ 2009-2015 Director, Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine |
|
･ 2003-2009 Director, Hepatitis Research Center, National Taiwan University Hospital ･ 2004-2005 Secretary General, Taiwan Association for the Study of Liver ･ 2003-2006 Vice Secretary General, Gastroenterological Society of Taiwan Publication Professor Kao’s main research interests include the prevention, natural history, molecular virology, pathogenesis and treatment of chronic viral hepatitis and HCC. He has published more than 410 articles with the sum of times cited of 19382 and h-index of 66 by Google Scholar or the sum of times cited of 12191 and h-index of 52 by Web of Science. He also contributed to 9 book chapters. Awards and Honors ･ 2013 Member, WGO Hepatology Interest Group/ Outstanding Research Award of Distinguished ･ 2014 Research Fellow, Ministry of Science and Technology ･ 2014 Board Director, APDW foundation ･ 2015 National Chair Professorship, Ministry of Education, Executive Yuan, Taiwan ･ 2015 AASLD Fellowship |
|
Dr. George LauChairman, Humanity and Health Medical Group |
|
 |
Dr George Lau graduated from The University of Hong Kong in 1987, with support by the King’s Edward Scholarship. After graduation, he was trained in Internal Medicine and then specialized in Gastroenterology and Hepatology and obtained his fellowship from the Hong Kong College of Physician in 1995. He received his post-doctorial training in Hepatology at Stanford University from 1992-1994 (supported by Hong Kong-Stanford scholarship) and University College of London from 1998-1999 (supported by Royal College scholarship). |
In 2002, he was promoted to Senior Lecturer and Consultant at the Department of Medicine, Queen Mary Hospital, The University of Hong Kong. At the same year, he awarded most understanding Youth in Hong Kong. In 2005, he became the Global Principal Investigator of pegylated interferon alfa-2a for the treatment of chronic hepatitis B (CHB) and his work led to the registration of pegylated interferon alfa-2a by the EU and US Food and Drug Administration in 2005 (published in the New England Journal of Medicine). Dr. Lau has more than 500 publications with citation of over 10,000. He has also been invited to give numerous lectures in Hepatology throughout the world. Dr Lau had been the Associate Editor for both Journal of Hepatology and Liver international, and is currently serving as reviewer for over 30 international journals. In 2006, he was promoted to full Professor and assistant Dean, Faculty of Medicine, The University of Hong Kong. He was admitted to Fellow of the Royal College of Physician (London) in 2006. He was also well respected by his peer in academic Hepatology and was elected as 19th President of the Asian Pacific Association of the Study Liver (APASL) in 2008-2009. With his contribution in the field, he is now life-member of the Steering committee of APASL. In 2015, he was made fellow of the American Association for the study of Liver Diseases. In 2016, he was awarded National Science and Technology Progress Award (State Science and Technology Prizes)- Technological Advancement in Chronic hepatitis B infection management (China). In his community work, Dr Lau has founded the Cheng Si-Yuan (China-International) Hepatitis Research Foundation in 1998 (http://www.csyfoundation.org). This foundation represents one of the largest non-profit organisation in liver diseases in Asia. In 2009, he founded and become Chairman of Humanity and Health Medical Group, Hong Kong. He was also Director and Consultant, Humanity and Health GI and Liver Center in Hong Kong. He is also the co-Director, Institute of Translational Hepatology and Director of the Beijing 302-Humanity and Health special hepatitis C clinic, 302 Hospital, Beijing, China. Beijing. Currently, he serves as the Chairman of the APASL HBV guideline committee and panel member of the APASL HCV guideline committee. He also served as the abstract reviewers of the 2015/2016 AASLD, DDW and APASL annual scientific meeting. |
|
Dr. Mei-Hsuan LeeAssociate Professor, Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan |
|
 |
Education 2004-2010, Ph.D., Graduate Institute of Epidemiology, College of Public Health, National Taiwan University Research Experiences 2010¬-2012, Postdoctoral Fellow, Genomics Research Center, Academia Sinica |
|
2015, Visiting Scholar, Genomics Research Center, Academia Sinica 2012-2016, Assistant Professor, Institute of Clinical Medicine, National Yang-Ming University Journal Editorial Board 2014-2017 World Journal of Hepatology 2014- Scientific Reports |
|
Dr. Laurentius A. LesmanaProfessor in Internal Medicine, Consultant Gastroentero-Hepatologist, Department of Medicine, University of Indonesia |
|
 |
Professor in Internal Medicine, Consultant Gastroentero-Hepatologist , Department of Medicine, University of Indonesia and Dr. Cipto Mangunkusumo teaching hospital, Jakarta.He received fellowship from the University of Amsterdam ,the Netherlands at the Department of Gastroenterology and Hepatology in 1979-1980 ( Prof. G.N.Tygtat).From 1986-1989 Ph.D Research Fellow,Department of Gastroenteology, Univ. of Amsterdam, the |
|
Netherlands.He underwent postgraduate training at the Department of Medicine , Chiba University , Japan in 1980.He received Fellow American College of Gastroenterology ( FACG ) in 1999 and Fellow of the American College of Physicians (FACP ) in 2001.He was the president of the Indonesian Association for the Study of the Liver ( Ina ASL) form 2002 -2006.Prof. Lesmana was the President of the first Annual APASL ( Asian Pacific Association of the Study of the Liver ) Conference 2005 in Bali and he was also the Chairman of the first China –Indonesia joint meeting ( CISHMS) in 2007 in Bali. He was the president of the first APASL Single Topic Conference on Hepatocellular Carcinoma in 2008 in Bali. His professional memberships include the American College of Gastroenterology, the American College of Physicians, the American Association for the Study of Liver Diseases, the American Society for Gastrointestinal Endoscopy.From 2005-now he is a member of the Steering Committee of APASL. He has published papers in national and international journals and currently a member of editorial board of ACTA and Hepatology International. He received Fellow of the American Association forthe Study of the Liver .( FAASLD ) in 2015 Prof Lesmana is currently the Chairman of Digestive Disease and GI Onkology Centre , Medistra hospital. |
|
Dr. Junqi NiuProfessor, Principal Investigator, Director of Department of Hepatology, First Hospital of Jilin University, Changchun, China |
|
 |
Personal Statement MD, Ph.D, Director of primary physician, medical professor and doctoral tutor. Outstanding contributions in the diagnosis and treatment of infectious diseases, especially liver disease. For the optimization of clinical treatment of hepatitis B and hepatitis C tireless exploration. Fund currently total about 65 million yuan in the research. The ongoing projects include:1. immune tolerance |
|
and immune clearance mechanism for chronic hepatitis B; 2. Study how HCV infection induces and evades host innate immune responses. 3. HCV infection and virus-host interactions at the molecular and cellular levels. Positions 1988-1992 Assistant professor and Physician, Norman Bethune Medical University, China 1992-1994 Visiting Fellow, St. Mary’s Hospital, London, United Kingdom 1994-1997 Associate Professor and consultant Physician, Norman Bethune Medical University, China 1997-1999 Senior Visiting Fellow, University of Connecticut Health Center, Farmington, Connecticut, USA 1999-2007 Professor, Chief of Department of Infectious Diseases, First Hospital, University of Jilin 2007-2013 Professor, Vice President of First Hospital, University of Jilin 2013-Present Professor, Principal Investigator, Director of Department of Hepatology, First Hospital of Jilin University Major Honors and Awards 2005: Awards of the first batch of top creative talents Jilin Province 2008: Young experts with outstanding contributions, Ministry of Health 2009: Top Ten famous doctors of Jilin University 2010: Special Award of State Government 2011: Award for Senior Expert of Jilin Province |
|
Dr. Shiv K SarinSenior Professor and Head, Department of Hepatology, & Director, Institute of Liver and Biliary Sciences (ILBS), New Delhi, India |
|
 |
Dr. Shiv Kumar Sarin obtained his M.B., B.S. degree with seven gold medals (1974), his MD in General Medicine (1978) from Rajasthan University, and his Fellowship in Gastroenterology from the All India Institute of Medical Sciences, in 1981. He served at the G.B. Pant Hospital, University of Delhi in 1983, becoming the Director Professor and Head of Gastroenterology in 1997. He is currently the Senior Professor and Head, Department of Hepatology and Director, Institute of Liver and Biliary Sciences. He is also the Director, WHO |
|
collaborative center on Viral hepatitis and Liver Diseases at ILBS, New Delhi India. He serves as Adjunct Faculty, Molecular Medicine at JNU due to his deep interest and contributions to translational science. During his academic career spanning 35 years, Prof. Sarin contributed immensely to the field of Hepatology. These include “Sarin’s Classification of Gastric Varices”; variceal band ligation as primary prophylaxis which was a landmark NEJM paper;. He defined new disease entities, portal biliopathy and acute and chronic liver failure His seminal contributions on liver regeneration using growth factors have the potential for providing non-transplant options to ACLF patients. He has more than 470 publications, helped develop 18 major guidelines and edited 13 books. He is the founding Co-Chief Editor of Hepatology International. Prof. Sarin was privileged to mentor 86 fellows and 25 Ph.D. students, and 25 of these head or serve as teaching faculty, including many in the US. He started the APASL School of Hepatology and was instrumental in setting up a Dedicated Liver University, the Institute of Liver and Biliary Sciences (ILBS) in India. ILBS was recently designated as the first WHO Collaborative Center globally in Liver Diseases. Prof. Sarin has been bestowed with Padma Bhushan (third highest civilian award of the country) by the Govt of India. He is a member of all the three science academies of the country. He has been a recipient of Shanti Swarup Bhatnagar award, the highest Award in Science in India, The World Academy of Medical Sciences International Prize, EASL International Recognition Award and ‘Most Distinguished Physician from India” from the American Association of Physicians of India, Fograty Fellowship of the NIH to work at University of Yale, and Senior Fellowship of the Japanese Society for Promotion of Science to work at Chiba, Japan. He was instrumental in setting up the Institute of Liver and Biliary Sciences (ILBS), under the auspices of the Govt of Delhi. ILBS has been conferred the status of a Deemed-to be University by the Govt. of India and is the first dedicated ‘Liver University’, globally. ILBS has been designated as the first WHO Collaborative Center in the world in the field of Liver Diseases. Prof. Sarin has shown leadership roles in being the President of the Indian Society of Gastroenterology, Indian Association for the Study of the Liver, Asian Pacific Association of Liver (APASL) and Chairman Steering Committee of the APASL. Prof. Sarin was nominated to lead the Medical Council of India (MCI) as the Chairman of the Board of Governors, 2010-2011. He developed the ‘Vision 2015’ document for Medical Education in India and had introduced far reaching reforms. |
|
Dr. Barjesh Chander SharmaProfessor, Department of Hepatology |
|
 |
Experience in Gastroenterology 1. Senior Resident(Hepatology):2 years:PGIMER, Chandigarh. 2. DM Resident(Gastroenterology):3 years:SGPGIMS, Lucknow 3. Senior Research Associate(Gastroenterology):13 months:GB Pant Hospital, Delhi, PGIMER, Chandigarh 4. Assistant Professor(Gastroenterology):33 months:PGIMER, Chandigarh |
|
5. Associate Professor(Gastroenterology):5 years and 3 months:GB Pant Hospital, Delhi 6. Professor(Gastroenterology):11 years:GB Pant Hospital, Delhi 7. Professor (Hepatology) Since 28/3/2016 ILBS Research Experience 1. Papers published : 215 2. Submitted for publication : 8 3. Papers presented/abstracted : 240 4. Conferences/Workshops attended : 58 Journal Editor, Member and Office Bearer of Scientific Committees and Societies 1. Secretary-General cum Treasurer of APASL. 2. Member of Steering Committee of APASL. 3. Chairman of Guidelined Committee of APASL 4. Member of Executive Council of APASL. 5. Member of Indian Society of Gastroenterology. 6. Member of Society of Gastrointestinal Endoscopy. 7. Member of Indian Association for Study of Liver Diseases. 8. Member of Asian Pacific Association for Study of the Liver 9. Editor - Journal of Gastroenterology and Hepatology 2004; 19: Supplement - Postgraduate course and current reviews in Hepatology, 14th Biennial Conference of Asian Pacific Association for the study of the Liver 10. Assistant Editor for Journal “Hepatology Intennational” 11. Member of Editorial Board of ‘ World Journal of Gastroenterology’. 12. Member of Editorial Board og J Gastroenterol Hepatol. 13. Member of Editorial Board of Journal of Clinical and Experimental |
|
Dr. Jose D. Sollano, Jr.Professor of Medicine, University of Santo Tomas, |
|
 |
Jose D. Sollano, Jr., is Professor of Medicine at the University of Santo Tomas Faculty of Medicine and Surgery, Manila, the Philippines. His major research interests include chronic hepatitis B and C, hepatocellular carcinoma, portal hypertension. He has published several original scientific works in peer-reviewed journals and is also a reviewer and/or member of the |
|
Editorial Board of several international periodicals in Gastroenterology, Endoscopy and Hepatology. He has been Faculty and/or Convenor of several Asian-Pacific Consensus Guidelines, including those on Chronic Hepatitis B, Chronic Hepatitis C, Portal Hypertension and Non Variceal Upper GI Bleeding. Prof. Sollano is a Past President of the Asia Pacific Association for the Study of the Liver (APASL). He is also Past President of the Hepatology Society of the Philippines, Philippine Society of Gastroenterology and Digestive Endoscopy, as well as, the Philippine College of Physicians. He is a member of the Chronic Hepatitis B Global Guidelines Task Force of the World Gastroenterology Organization (WGO). |
|
Dr. Seung Kew YoonProfessor, Division of Hepatology and Gastroenterology |
|
 |
Seung Kew Yoon, MD is now a professor of the division of Hepatology and Gastroenterology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea. Dr. Yoon earned his MD at the Catholic University of Korea in 1985. He trained in Hepatology & Gastroenterology at Seoul St.Mary’s Hospital, The Catholic University of Korea from 1992 to 1994. He then subsequently trained as |
|
research fellow in Molecular Hepatology Laboratory, MGH, Harvard Medical School, Boston, USA from 1996 to 1998. He has been principal investigator in several international multicenter researches on antiviral therapy against hepatitis virus B & C, and target therapy for HCC. He holds scientific membership in numerous professional associations in Korea and is a member of the American Association for the Study of Liver Diseases (AASLD), EASL and APASL. He served as a secretary general of Korean Association for the Study of the Liver (KASL) from 2013 to 2015. Also, He served as a secretary general of APASL STC 2016 in Busan. He works as a director of Liver Cancer Center in Seoul St,Mary’s Hospital and Catholic University Liver Research Center. He has published more than 200 authored and co-authored original articles on the viral hepatitis B and C, NASH, and HCC. He had also written chapter on molecular diagnostics of HCC in the textbook “Principles of Molecular diagnostics and personalized cancer medicine” |
|
Dr Ming Lung YuProfessor, Kaohsiung Medical University and Hospital |
|
 |
Ming-Lung Yu, MD, PhD, is a Distinguished Professor at the College of Medicine, Kaohsiung Medical University, Taiwan. Professor Yu graduated from the College of Medicine at Kaohsiung Medical University in 1989 before going on to obtain a PhD from the Graduate Institute of Clinical Medicine in 2000. Professor Yu, a board-certified internist and gastroenterologist, is currently teaching at the Kaohsiung Medical University and Kaosiung Medical University Hospital where |
|
he is holding the leading role of Hepatitis Center and Hepatobiliary section, Department of Internal Medicine. Currently, he is also a Visiting Professor at Liver Center, Division of Gastroenterology, Massachusetts General Hospital, Boston, MA, USA. Professor Yu’s research interests in epidemiology and natural history of viral hepatitis have led him to publish more than 250 journal and review articles. Professor Yu has won numerous awards over his career in recognition of his research. In addition to his academic and clinical achievements, Professor Yu also holds various editorial roles with several scientific journals some of which include PLoS ONE, World Journal of Gastroenterology, and Korean Journal of Hepatology He also frequently serves as a reviewer for major international journals in medicine, gastroenterology and hepatology, such as The Lancet, Gastroeneterology, Hepatology, Gut, Journal of Hepatology, Clinical Infectious Disease, Canadian Medical Association Journal, Thorax, Ontotarget, Pharmacology & Therapeutics, Scientific Reports and Journal of Infectious Diseases. |
|
Dr. Xinxin ZhangProfessor of infectious diseases, Director of Research Laboratory of Clinical Virology, Rui Jin Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai, China |
|
 |
Professor Xinxin ZHANG, graduated from Shanghai Second Medical University in 1987. She is currently a Professor of infectious diseases, Director of Research Laboratory of Clinical Virology, Rui Jin Hospital, Shanghai Jiao Tong University, School of Medicine. Professor Xinxin ZHANG is also a vice chairman of Shanghai Hepatology Society, a member of Chinese Hepatology Society, an honorary Chairman of Shanghai |
| Medical Virology Society, a member of administration board of Tropical Diseases Institute Francophone, a Chairman of post-doc club of Chinese French Foundation. More than forty national and international collaboration scientific research grants have been obtained successfully since recent years and 176 papers have been published including 49 publications on international journals, such as Gut, Journal of Hepatology, Antiviral Therapy, Clinical Microbiology & Infection, Journal of Clinical Microbiology. | |
Invited Guests from Japan
Dr. Yuko AkazawaLecturer, Department of Pathology, Nagasaki University |
|
 |
Education 2000: MD. Nagasaki University School of Medicine Hospital and Research appointments: 2000-2001: Resident, Second Department of Internal Medicine, Nagasaki University School of Medicine 2001: Resident, Nagasaki Municipal Hospital |
|
2001-2002: Resident in Second Department of Radiology, Nagasaki University School of Medicine 2002-2004: Staff, Department of Internal Medicine, Omura Municipal Hospital 2004-2010: Second Department of Internal Medicine, Nagasaki University Graduate School of Biomedical Sciences 2006-2009: Research fellow, Mayo Clinic, Department of Gastroenterology and Hepatology, Gregory Gores laboratory 2010-2013: Assistant professor, Department of Gastroenterology and Hepatology, Nagasaki University Hospital 2013-2014: Assistant professor, Departments of Tumor and Diagnostic Pathology, Atomic Bomb Disease Institute, Nagasaki University 2015-2016: Assistant professor, Department of Health informatics, Nagasaki University 2016 Aug~: Lecturer, Department of Pathology, Nagasaki University |
|
Dr. Yasuhiro AsahinaProfessor, Department of Gastroenterology and Hepatology |
|
 |
Professor Yasuhiro Asahina studied medicine at Shiga University of Medical Science and graduated in 1988. Following this, he completed a clinical fellowship in Tokyo Medical and Dental University Hospital followed by a research fellowship at University of Connecticut Health Center in the USA and Tokyo Medical and Dental University, where he received his Ph. D. degree in Medical Science in 1996. Professor Asahina is currently a Professor at the Department of Liver Disease Control, Tokyo Medical Dental University (TMDU) since 2012. |
|
Professor Asahina has published 270 scientific papers and 37 books, and has given 284 lectures in the area of his expertise as an invited speaker, symposiast, and panelist. He serves as a Council Board Member for Japan Society of Hepatology, a Council Board Member for Japanese Society of Gastroenterology, a Council Board Member for Japan Gastroenterological Endoscopy Society, a Fellow of the Japanese Society of Internal Medicine, and an International Member for American Association for the Study of Liver Diseases. His research interests are "Molecular mechanisms for viral hepatitis and hepatocarcinogenesis, and diagnosis and treatment of viral hepatitis and HCC ". He has many experiences of anti-hepatitis viral treatment, and molecular targeted therapy and radiofrequency ablation for HCC. |
|
Dr. Kazuaki ChayamaProfessor, Department of Gastroenterology and Metabolism, |
|
 |
Education 1981: Graduated from Hiroshima University 1981: Medical Doctor’s license in Japan 1997: PhD of Medical Science from Tokyo University for a thesis entitled “Nucleotide sequence and genome organization of a rare hepatitis C virus genotype (genotype 3b) isolated from a Japanese patient with Chronic hepatitis C. |
|
Occupation 1981: Doctor, Department of Internal Medicine, Mimihara General Hospital 1986: Doctor, Department of Internal Medicine, Toranomon Hospital 1996: Head Physician, Department of Internal Medicine, Toranomon Hospital 2000: Professor of Medicine, Faculty of Medicine, Hiroshima University 2002: Professor, Department of Gastroenterology and Metabolism, Applied Life Sciences, Graduate School of Biomedical & Health Sciences, Hiroshima University 2011, April-2015, March: Director of Hiroshima University Hospital 2012, April-2015, March: Executive and Vice President (Medical Affairs), Hiroshima University Special fields Gastroenterology, Viral Hepatitis |
|
Dr. Nobuyuki EnomotoProfessor of Gastroenterology and Hepatology, University of Yamanashi |
|
 |
Nobuyuki Enomoto, MD, is Professor of Gastroenterology and Hepatology at University of Yamanashi in Japan. He trained in Medicine at Tokyo Medical and Dental University since 1984, studied on HCV genotypes at Kanazawa Medical University and completed a PhD in Molecular Virology about the interferon sensitivity of HCV at Tokyo Medical and Dental University in 1996. He moved to Yamanashi from Tokyo in 2003. |
| Prof. Enomoto is now a board member of Japan Society of Hepatology. He has authored and co-authored a number of papers that have published in peer-reviewed journals in the field of liver diseases. He runs clinical researches studying the treatment of hepatitis and HCC as well as basic researches on HCV genetics with the next-generation sequencing technique. | |
Dr. Yoshikatsu EtoDirector of Advanced Clinical Research Center, Institute of Neurological Diseases Professor Emeritus, Jikei University School of Medicine |
|
 |
Prof. Eto is currently a Director of Advanced Clinical Research Center, Institute of Neurological Diseases and Professor Emeritus, Jikei University School of Medicine. He served as a Professor and chairman, Department of Pediatrics, Director of DNA Institute for Medical Science and also Vice President, University Hospital, the Jikei University School of Medicine. Prof. Eto studied for more than 40 years in the field of lysosomal storage diseases and has left many |
| achievements. He also served as a President of Japan Pediatric Society for four years and also as a President of Japan Society of Inherited Metabolic Disorders for 7 years. He has been leading the research in Pediatrics in Japan. Internationally, he also serves as a Standing Committee Member of International Pediatric Association for 6 years and as a President of the 10th International Congress of Inborn Error of Metabolism, 2006, Tokyo. He contributed to the establishment of Asian Society of Pediatric Research (ASPR) and is also a founder of Japan Society of LSD. He published more than 350 English written peer reviewed papers. Currently, he has studying about clinical and basic research in LSD, particularly, Fabry disease, Pompe disease and genetic leukodystrophy including NPC and also iPS research in LSD, as well. | |
Dr. Etsuko HashimotoProfessor, Department of Internal Medicine and Gastroenterology, Tokyo Women’s Medical University |
|
 |
Education 1971-1977: Tokyo Women’s Medical University Position Held 1977-1983: Internship and residency in Department of Internal Medicine and Gastroenterology, Tokyo Women’s Medical University |
|
1983-1987: Fellowship 1987-1989: Visiting Scientist at Mayo Clinic, Rochester MN, USA. 1989-1996: Fellowship in Department of Internal Medicine and Gastroenterology, Tokyo Women’s Medical University 1996-2005: Assistant Professor of Internal Medicine and Gastroenterology 2005-2007: Associate Professor of Internal Medicine and Gastroenterology 2007-: Professor of Internal Medicine and Gastroenterology Biography Etsuko Hashimoto is a professor of Hepatology and Gastroenterology at Tokyo Women’s Medical University. She had the privilege of studying liver pathology under Professor Ludwig, who is a renowned pathologist at MAYO Clinic, from 1987 to 1991. Professor Ludwig is well known as he established the concepts and the definition of NASH. At present, her primary area of interest is in the field of NASH, specifically in elucidation of the characteristics of HCC in NASH, the risk of development of HCC, and strategies for management of NASH. |
|
Dr. Yoichi HiasaProfessor, Department of Gastroenterology and Metabology, |
|
 |
Professor Yoichi Hiasa was graduated with M.D. degree in 1990 from Ehime University School of Medicine, Ehime, Japan. Then he was graduated with Ph.D. degree in 1999 from Ehime University Graduate School of Medicine, Ehime, Japan. During the period of graduate school student, he worked and trained basic research in Tokyo Metropolitan Institute of Medical Sciences (head is Dr. Michinori Kohara), Tokyo, Japan. After obtaining the Ph.D. degree, he worked as |
| a post doctoral fellow under the laboratory of Dr. Raymond T. Chung at Massachusetts General Hospital and Harvard Medical School, Boston, USA. After going back to Ehime University, he worked as an assistant professor, lecturer and associate professor of the department of Gastroenterology and Metabology in Ehime University Graduate School of Medicine (professor is Dr. Morikazu Onji). In 2013, he was promoted as a chief professor of the department, and in 2015, was also promoted as a vice director of Ehime University Hospital. His research interests are hepatocellular carcinoma, viral hepatitis and lifestyle-related diseases, including non-alcoholic fatty liver diseases (NASH). He now conducting several basic research, clinical research and epidemiologic research, and published in fields of molecular biology, immunology, diagnostic imaging, nutrition and epidemiology. Moreover, he is now managing international collaborating projects for viral hepatitis and hepatocellular carcinoma. He would be expected as one of the young leaders of gastroenterology and hepatology in Japan. | |
Dr. Keisuke HinoProfessor and Chairman, Department of Hepatology and Pancreatology, Kawasaki Medical School |
|
 |
Keisuke Hino has been a Director of the Department of Hepatology and Pancreatology at Kawasaki Medical School, Kurashiki, Japan since 2008. He graduated from Yamaguchi University School of Medicine in 1982 and received PhD from Yamaguchi University in 1989. He was a research fellow in University of Glasgow, Institute of Virology from 1996 to 1997. He was a professor of Laboratory Sciences, Yamaguchi University Graduate School of Medicine from 2005 to 2008. Professor Hino has a long-term research interest in liver diseases |
| with a main focus on the area of Hepatitis C-host interactions. In particular, he has contributed major advances in the impact of HCV on iron metabolism, oxidative stress and mitochondrial function. He has published extensively in this area since 2000 and has published prominent papers in Nature Genetics, Gastroenterology and Hepatology. His most significant research accomplishment was his detailed study of the HCV on hepatic hepcidin production and iron accumulation. This landmark study published in two papers in Gastroenterology showed the direct effect of HCV on hepatocyte transcription of hepcidin and its impact on iron accumulation and hepatocellular carcinoma. This work was the first discovery of the mechanism behind association between hepatitis C and hepatic iron accumulation and showed the importance of this phenomenon to HCV-associated hepatic carcinogenesis. He plays leadership roles in the Japanese Society of Internal medicine, the Japanese Society of Hepatology and the Japanese Society of Gastroenterology. He is well acknowledged as one of the leaders of Hepatology in Japan and brings great perspective and experience to his International collaborations. He has been conducting the Research Program on Hepatitis from Japan Agency for Medical Research and Development (16fk0210xxxh0001) since 2016. He has received many honors and awards including the Uehara memorial Foundation Postdoctoral Fellowship Award and the Japanese Society of Hepatology Shering Plough Award. | |
Dr. Takafumi IchidaDirector of Shonan-East General Hospital |
|
 |
Takafumi Ichida, MD was graduated from the Niigata University School of Medicine in 1975. After graduation, he continued to training on hepatology field at Free University of Brussel (E Wisse) in Belgium, Department of Cell Biology 1984 and Naylor Dana Cancer Institute at American Health Foundation (GM Williams) in New York, 1985. In 1991, he went abroad again in Pittsburgh Transplantation Center (T Starzl, S Iwatsuki, S Todo and DH Van Thiel) to learn and investigate the liver transplantation for the establishment of living and |
|
deceased donor liver transplantation in Japan In 2004, he became Professor of Gastroenterology and Hepatology of Juntendo University Shizuoka Hospital (Japan).He engaged management of both viral hepatitis and hepatocellular carcinoma, and liver transplantation. He is opinion leader of the field of liver transplantation in Japan. In 2014, he became the Director of Shonan-East General Hospital at Kanagawa Prefecture. Now his practice is focused on education of hepatologist, management of patients of all kind of liver diseases, and he is still acting as a chairman of Evaluation Committee of Deceased Donor Liver Transplantation in Japan. Research Interest: Viral hepatitis, Hepatocellular carcinoma, Liver transplantation, Electron microscopy, Hepatocarcinogenesis |
|
Dr. Namiki IzumiDirector of Department of Gastroenterology and Hepatology, Musashino Red-Cross Hospital and Clinical Professor, Tokyo Medical and Dental University |
|
 |
Namiki Izumi is the President of Musashino Red Cross Hospital and Director of Department of Gastroenterology and Hepatology of the hospital, as well as the invited professor of Tokyo Medical and Dental University. He received his medical degree at the Tokyo Medical and Dental University in Japan. He served his residency in medicine and fellowship in the second department of Internal Medicine at the hospital of Tokyo Medical and Dental. |
|
Namiki Izumi is an active board member of the Japanese Society of Hepatology, currently serving on the Guideline committee member of viral hepatitis and the social insurance committee as chairman. In 2014, He served as the president for 50th anniversary meeting of Japan Society of Hepatology in Tokyo. He is also an active board member of the Japanese Association for Liver Cancer, currently serving on the Guideline committee member of hepatocellular carcinoma. He has served as Chief Investigator of study groups funded by Japanese Ministry of Health, Welfare and Labor (MHLW) for clinical study of viral hepatitis and hepatocellular carcinoma and data mining analysis for chronic hepatitis C. He has an active practice and serves as a principal investigator on many important trials involving antiviral therapy for both hepatitis B and C. Namiki Izumi has a special interest in chronic viral hepatitis and hepatocellular carcinoma, focusing on the epidemiology, natural history and antiviral therapies for these diseases. |
|
Dr. Masayoshi KageProfessor Emeritus, Kurume University School of Medicine |
|
 |
Education and Professional Experience March 1977 MD from Kurume University School of Medicine April 1977-March 1981 Post Graduate School in Pathology, Kurume University |
|
April 1981-September 1982 Fellow in Pathology, Kurume University School of Medicine October 1982-March 1993 Lecture in Pathology Kurume University School of Medicine November 1982-June 1983 Visiting Fellow in Pathology, Rancho Los Hospital, Amigos University Southern California April 1992-June 2001 Associate Professor in Pathology, Kurume University School of Medicine July 2001-March 2016 Professor in Pathology, Kurume University School of Medicine July 2001-March 2016 Director in Department of Diagnostic Pathology, Kurume University Hospital April 2008-Marh 2016 Director in Molecular Targeting Therapeutics Division Research Center for Innovative Cancer Therapy, Kurume University April 2013-Marh 2016 Director in Research Center for Innovative Cancer Therapy, Kurume University April 2016-Present Professor Emeritus, Kurume University School of Medicine Membership The Japan Society of Hepatology (Director) The Japan Society for Portal Hypertension (Vice President) The Japanese Association of Pathology (Councillorship) The Japan Society for Pediatric Gastroenterology, Hepatology and Nutrition (Councillorship) International Association Study of the Liver Asian Pacific Study of the Liver Presidents of conferences 2005 The 32rd General Meeting of the Japan Society for Pediatric Gastroenterology, Hepatology and Nutrition 2008 The 15rd Annual Meeting of The Japan Society for Portal Hypertension 2008 The 7rd Single Topic Conference “Abnormal hepatic hemodynamics” 2015 The 19rd General Meeting of the Japan Society |
|
Dr. Tatsuo KandaAssociate Professor at Department of Gastroenterology and Nephrology, Chiba University, Graduate School of Medicine |
|
 |
Tatsuo Kanda received a medical degree in 1991 at Niigata University School of Medicine, Japan, and participated in First Department of Internal Medicine, Chiba University, School of Medicine. Tatsuo Kanda received his PhD in 1999 at Chiba University Graduate School of Medicine, Japan. He had post-doctor training for 3 years under Prof. Ratna Ray and Prof. Ranjit Ray at Saint Louis University, St. Louis, MO, USA. In Dec. 2008, Tatsuo Kanda became a Tenure- |
| track Associate Professor at Department of Medicine and Clinical Oncology, Chiba University, Graduate School of Medicine, Japan. In Feb. 2013, Tatsuo Kanda was nominated a permanent Associate Professor at Department of Gastroenterology and Nephrology, Chiba University, Graduate School of Medicine, Japan. For ~25 years, he has focused his scientific interests on the topics related to liver diseases including acute liver failure, viral hepatitis and autoimmune liver diseases, and worked with Prof. Osamu Yokosuka. Tatsuo Kanda is also an expert for hepatitis A virus (HAV), HBV and HCV, and translation and replication of these viruses, and hepatocarcinogenesis. With his expertise in antiviral therapies and hepatitis virus research, Tatsuo Kanda also sees a lot of patients in clinical daily practice. Tatsuo Kanda has published more than 200 articles in peer-reviewed Journals such as Hepatology, Journal of Virology and Cancer Research. Tatsuo Kanda also participated in the APASL working party for HCV guidelines. | |
Dr. Shuichi KanekoProfessor of the Department of Gastroenterology, Kanazawa University Hospital |
|
 |
Dr. Shuichi Kaneko has been a Professor of the Department of Gastroenterology, Kanazawa University Hospital from 2004. He received his MD in 1982 and PhD in 1986 from Kanazawa University. He had served as a Visiting fellow of the National Institutes of Health (NIH), USA from 1987 to 1989 and a Visiting professor of University of Southern California, USA from 1993 to 1995. He is a Visiting professor of Sichuan University from 2007. |
| His research interests are liver diseases with a main focus on viral hepatitis, and hepatocellular carcinoma. Dr. Kaneko was a President of the 48nd Annual Meeting of Japan Society of Hepatology in 2012. He has been a Board member of directors of the Japanese Society of Gastroenterology from 2011. Dr. Kaneko has received many honors and awards including the Japanese Ministry of Education, Culture, Sports, Science and Technology, Science and Technology Award in 2014, the “Khubilai Khan” Gold Medal of the Mongolian Academy of Sciences and the Minister Award of Japanese Ministry of Economy, Trade and Industry, Industry-Academia-Government Collaboration Service Award in 2015. Now Dr. Kaneko is a Dean of Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University. | |
Dr. Tatsuya KantoDirector General, The Research Center for Hepatitis and Immunology National Center for Global Health and Medicine |
|
 |
Education 1995: Ph.D (Hepatology). Osaka University Graduate School of Medicine 1986: M.D (Medicine). Osaka University Graduate School of Medicine Professional Background 2016~: Director General, The Research Center for Hepatitis and Immunology |
|
National Center for Global Health and Medicine 2015~2016: Director, Department of Hepatic Diseases, National Center for Global Health and Medicine, The Research Center for Hepatitis and Immunology 2013~2015: Chief, Division of Advanced Medical Technology for Hepatic Diseases, National Center for Global Health and Medicine, The Research Center for Hepatitis and Immunology 2003~2013: Associate Professor in the Department of Gastroenterology and Hepatology, Department of Dendritic cell Biology and Clinical Applications, Osaka University Graduate School of Medicine 2001~2003: Assistant Professor in the Department of Molecular Therapeutics, Osaka University Graduate School of Medicine 1998~2001: Research Associate, Department of Surgery, Pittsburgh University, Pittsburgh PA, USA 1992~1998: First Department of Medicine, Osaka University Graduate School of Medicine Special Fields Viral Hepatitis, Liver cancer, Immunology |
|
Dr. Norifumi KawadaProfessor of Medicine |
|
 |
Professor Norifumi Kawada was graduated with M.D. degree in 1986 from Osaka City University Medical School. He obtained his Ph.D. degree from Osaka City University in 1991. From 1991 to 1992, Prof. Kawada trained as a Visiting Scientist, Institute of Biochemistry, Freiburg University. And then, from 1993 to 2006, he worked as a Research Associate, Assistant Professor, and Associate Professor in Osaka City University Graduate School of Medicine. |
| He was promoted as a professor of Osaka City University Graduate School of Medicine in 2007. His research interests are biology of stellate cells, liver fibrosis, and carcinogenesis. He is a reviewer and member of editorial board of several scientific journals. Prof. Kawada was Visiting Scientist, Department of Hepatology, Florence University in 2004, and from 2015, he is a visiting Professor of University College London (UCL). He assumes a fellow of American Association for the Study of Liver Diseases (AASLD) in 2015. | |
Dr. Kazuhiko KoikeProfessor and Chairman |
|
 |
Dr. Koike obtained his M.D. degree from The University of Tokyo in 1980. From 1986 to 1989, he worked in the National Cancer Institute, Bethesda. In 2004, he has been appointed as the Professor and Chairman of Department of Infectious Diseases, and, in 2009, has been appointed as the Professor and Chairman of Department of Gastroenterology, The University of Tokyo. He has been the Director General of The Japan Society of Hepatology since 2010, and was |
|
Director General of The Japanese Society of Internal Medicine from 2013 to 2016. He is a board-certified hepatologist and board-certified gastroenterologist. He has been chiefly working on the clinical practice on viral hepatitis B & C, and diagnosis and treatment of hepatocellular carcinoma. He has published more than 600 original articles. |
|
Dr. Masatoshi KudoProfessor and Chairman, Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine |
|||
 |
Education Undergraduate Education: 1972-1974 Kyoto University, Kyoto, Japan |
||
| Medical Education: | 1974-1978 Kyoto University, School of Medicine, Kyoto, Japan 1978 M.D. Degree 1986 Ph.D. Degree |
||
|
Appointments 1978-1979: Internship, Kyoto University Hospital 1979-1985: Staff Member, Division of Gastroenterology, Department of Medicine, Kobe City General Hospital 1983-1987: Research Fellow, Departments of Diagnostic Radiology and Nuclear Medicine, Kyoto University, School of Medicine 1985-1987: Assistant Chief, Division of Gastroenterology, Department of Medicine, Kobe City General Hospital 1987-1989: Visiting Research Scholar, Divisions of Gastroenterology and Nuclear Medicine, Departments of Medicine and Radiology, University of California, Davis Medical Center 1989-1992: Assistant Chief, Division of Gastroenterology, Department of Medicine, Kobe City General Hospital 1992-1997: Associate Chief, Division of Gastroenterology, Department of Medicine, Kobe City General Hospital 1993-1998: Visiting Professor, Kobe University School of Medicine 1995-1998: Visiting Professor, Shiga Medical School 1995-1997: Chief, Section of Hepatology, Division of Gastroenterology Department of Medicine, Kobe City General Hospital 1997-1999: Associate Professor, Second Department of Internal Medicine, Kindai University Faculty of Medicine 1999-present: Professor and Chairman, Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine 2007-2008: Vice-president, Kindai University Medical Center 2008-2014: President, Kindai University Medical Center |
|||
Dr. Takashi KumadaClinical Professor |
|
 |
1977: Graduation of Nagoya University School of Medicine 1977-1982: Medical residency, Department of Internal Medicine, Ogaki Municipal Hospital 1982-1984: Attending staff, Section of Hepatology, Second Department of Internal Medicine, Nagoya University School of Medicine 1984-: Attending staff, Department of Gastroenterology and Hepatology, Ogaki Municipal Hospital |
|
2000-: Department director, Department of Gastroenterology and Hepatology, Ogaki Municipal Hospital 2011-: Deputy director of a hospital, Ogaki Municipal Hospital 2016-: Clinical professor, Nagoya University School of Medicine Specialty and Research Field of Interest Hepatology, Medical Oncology, Interventional Radiology, Treatment of hepatic Malignancies, Viral hepatitis. Internal scientific papers 204 |
|
Dr. Tsutomu MasakiProfessor and Chairman, Department of Gastroenterology and Neurology, |
|
 |
Education: 1994:Ph.D. (Doctorate of Medical Science), Kagawa University, Department of Internal Medicine 1990: M.D., Kagawa University School of Medicine |
|
Current research projects: A. Diagnosis and Treatment of Hepatocellular carcinoma B. Cell Cycle in Cancer Cell C. MicroRNA and Cancer Research ethics/ GCP training or experience: Chief director of IRB committee in Kagawa University |
|
Dr. Yasushi MatsuzakiDirector of the Department of Gastroenterology and Hepatology, |
|
 |
Professor Yasushi Matsuzaki is Director of the Department of Gastroenterology and Hepatology at Tokyo Medical University, Ibaraki Medical Center. He was graduated with M.D. degree in 1980 from University of Tsukuba, before completing postgraduate training at the Graduate School of Medical Science, University of Tsukuba, Doctor Course in Medical Science. He had a Doctor of Medical Science by-Thesis, University of Tsukuba in 1984, where he became |
|
Assistant Professor at Department of Gastroenterology and Hepatology, Institute of Clinical Medicine, University of Tsukuba form 1988 to 1999, and he was visiting Professor, at Division of Gastroenterology and Nutrition, Department of Medicine, The George Washington University, in USA. From 2000 to 2006, he became Professor and Chief, at Tokyo Medical University, Division of Gastroenterology and Hepatology, Tokyo Medical University, Ibaraki Medical Center. And then from 2009 to 2015, he was Hospital Director, Tokyo Medical University, Ibaraki Medical Center. Professor Matsuzaki has a long-term research interest in liver disease with a main focus on lipid and bile acid metabolism, hepatobiliary disease, autoimmune liver disease, viral hepatitis and hepatocellular carcinoma. He has a numerous professional affiliations, as follows; International Membership; American Gastroenterological Association, International Membership; American Association of Study of the Liver Disease, Active Member; American Association of Cancer Research, Active Membership; Asian Pacific Association of Study of the Liver, Active Member; The Japanese Society of Gastroenterology, Active Member; The Japanese Society of Hepatology etc. He is Editorial Board: Hepatology Research (Associate Editor), W J Gastroenterology. He organized NPO: Citizen oriented Health and Medicine Network and is a President of this NPO. He received numerous awards including Young Investigator Award of The Japanese Society of Hepatology, 1991, URSO prize of The Japanese Clinical Bile Acid Meeting, 1996, The 1st Ajinomoto Investigator Awards of The Japanese Society of Hepatology and Ajinimoto Co. 1999. He has published over 200 articles in international peer-reviewed journals such as The Lancet, Gastornterology and Hepatology among others. He has a total IF of 900 in 2015. |
|
Dr. Masashi MizokamiDirector General |
|
 |
Main research area Molecular evolutionary analysis in host and pathogen and its clinical significance Education and professional experience 1971-1976: Nagoya City University Medical School |
|
1978-1981: Gastroenterologist, Department of Gastroenterology, Chukyo Hospital 1981-1983: Researcher, under prof. Gojobori T, National Institute of Genetics 1983-1989: Assistant Professor, Nagoya City University Medical School 1990-1991: Clinical Research Fellow, Liver Unit, King’s College Hospital 1998-1999: Associate Professor, Nagoya City University Medical School 2000-2008: Director and Professor, Department of Clinical and Molecular informative Medicine, Nagoya City University Graduate School of Medical Sciences 2008-Present: Director General, Research Center for Hepatitis and Immunology, National Center for Global Health and Medicine |
|
Dr. Satoshi MochidaProfessor and Chairman, Department of Hepatology & Gastroenterology, Saitama Medical University Hospital, Vice President, Faculty of Medicine, Saitama Medical University |
|
 |
Professor Satoshi Mochida was graduated with the M.D. degree in 1984 from Faculty of Medicine, University of Tokyo. Dr. Mochida spent 3 years as a resident of internal medicine at University of Tokyo Hospital and Kodaira Memorial Tokyo Hitachi Hospital from 1984 to 1997. Then he worked as a clinical fellow in the First Department of Internal Medicine, Faculty of Medicine, University of Tokyo, under the instruction of Professor Kenji Fujiwara, and received the Ph.D degree in Medicine from University of Tokyo in 1995.He moved the Third |
| Department of Internal Medicine, Saitama Medical University as an assistant professor in 1994, and promoted to a senior lecture in 1995, an associated professor in 1998 and a professor in 2003. In the present, he is a professor and chairman of the Department of Gastroenterology & Hepatology and a vice president of Faculty of Medicine in Saitama Medical University. He has been active in many academic professional societies including the Japan Society of Hepatology (JSH), the Japanese Society of Gastroenterology (JSGE), the American Association for the Study of Liver Diseases (AASLD) and the Japan Society of Internal Medicine. In the Japan Society of Hepatology (JSG), he works as a director and chairman in the Planning and Public Relations Committee. His research interests are liver failure, liver transplantation, intractable liver diseases and viral hepatitis, and serves as a president of the Acute Liver Failure Group of Japan. | |
Dr. Makoto NakamutaDirector of Center for Liver Diseases, Kyushu Medical Center, National Hospital Organization |
|
 |
Dr. Makoto Nakamuta is Director of Center for Liver Diseases, Kyushu Medical Center, National Hospital Organization, Fukuoka, Japan. He is also a councilor of the Japan Society of Hepatology (JSH), and an associate editor of Hepatology Research (the offical jounal of JSH). He was graduated from Kyushu University with MD in 1984. After two years’ residency at Kyushu University Hospital, he entered Kyushu University Graduate School of Medicine, and obtained PhD in 1990. After receiving advanced clinical training, he spent three and a half year |
| as a research associate and subsquently as an instructor at Baylor College of Medicine, Houston TX, US from 1993 to 1996 where he investigated molecular biology of lipid metabolism, particularly ApoB editing. Since then, he has dedicated to lipid and glucose metabolism in liver diseases including NAFLD/NASH, viral hepatitis, and PBC. His recent research interest is roles of “multiple organ crosstalk” in steatosis among liver, pancreas (insulin and glucagon), brain (appetite center), adipose tissue (adipokine), muscle (myokines), and colon (microbiota). He is also intrigued by Sirtuin (NAD mtatolism) and bile acid metabolism (FXR and TGR5). He is basically a clinical physician and he always engages in clinical and basic research with an eye to clinical application. | |
Dr. Hiroyuki NakanishiDeputy Director, Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital |
|
 |
Undergraduate Education 1992-1998: Tsukuba University Medical Education 2005-2009: Yamanashi University, School of Medicine 2009: Ph.D Degree |
Appointments Apr 1998 - Mar 2000: Trainee in Tsukuba University Hospital Apr 2000 - Oct 2000: Dept. of Emergency Medicine, Tokyo Metropolitan Bokutoh Hospital Nov 2000 - Dec 2002: Dept. of Gastroenterology and Hepatology, Tokyo Metropolitan Bokutoh Hospital Jan 2003 - May 2003: Dept. of Gastroenterology and Hepatology, J. A. Toride Medical Center Jun 2003 - Mar 2009: Dept. of Gastroenterology and Hepatology, Musashino Red Cross Hospital Apr 2009 - Present: Deputy Director, Dept. of Gastroenterology and Hepatology, Musashino Red Cross Hospital Main Study Field Liver cirrhosis, Hepatocellular carcinoma |
|
Dr. Shuhei NishiguchiVice-President of Hyogo College of Medicine, and Professor, Dept. of Hepatobiliary Pancreatic Disease, Hyogo College of Medicine |
|
 |
Dr. Shuhei Nishiguchi is a Professor of the Department of Hepatobiliary Pancreatic Disease, Hyogo College of Medicine, Hyogo, Japan, since 2005, and a Vice-President of Hyogo College of Medicine since 2013. He received his MD (1981) and PHD (1985) in Medicine from Osaka City University. He spent one year as a research fellow in Salk Institute, La Jolla CA under the instruction of Dr. Renato Dulbecco who won the 1975 Nobel Prize in Physiology or Medicine for |
| his work on oncoviruses. He has authored over 400 peer-reviewed papers, has edited 5 books, and holds many patents. Prof. Nishiguchi has been associate Editor for Hepatology Research, Journal of Hepato-Biliary-Pancreatic Sciences, and Liver International. He is a director of the Japan Society of Hepatology, Japanese Society of Clinical Nutrition, and the Japanese Society of Interferon Cytokine Research, and Japanese Medical Society of Alcohol and Drug Studies. He is also a council of the Japanese Society of Internal Medicine, and the Japanese Society of Gastroenterology. His major research interests are diagnosis and treatment of viral hepatitis and prevention of hepatocellular carcinoma. | |
Dr. Hideyuki NomuraChief of the Center for Liver Disease, Shinkokura Hospital |
|
 |
Hideyuki Nomura, MD is the chief of the Center for Liver Disease, Shinkokura Hospital. Dr Nomura is the leader of KULDS (Kyushu University Liver Disease Study Group). KULDS is one of the largest clinical study groups for hepatitis C therapy (interferon or DAAs) in Japan. He graduated with M.D. in 1980 from Kyushu University, Japan and obtained Ph.D. from Kyushu University, Japan. He held an additional post of a clinical professor of Kyushu University Hospital |
| from 2013 through 2015. His research interests are viral hepatitis (particularly HBV and HCV), liver cirrhosis, and hepatocellular carcinoma. He has published many scientific papers. He is a reviewer of several scientific journal. | |
Dr. Shuntaro ObiProfessor Gastroenterology, Teikyo University School of Medicine Chiba Medical Center |
|
 |
Education/Post Graduate Training College/University: 1985-1991 MD, Teikyo University School of Medicine May 2007 PhD Gastroenterology Tokyo University School of Medicine #16800 |
|
Residency: 1991-1992 Tokyo Metropolitan Tama Medical Center, Tokyo, Japan 1992-1993 Tokyo University School of Medicine, Tokyo, Japan 1993-1995 General Hospital National Health Insurance Asahi Central Hospital, Chiba, Japan Medical Licensure 1991 Full Medical License (Japan) #340521 Board Certification Jan 1999 Fellow of the Japanese Society of Gastroenterology #29994 Sep 2005 Fellow of the Japanese Society of Internal Medicine #85489 Apr 2010 Fellow of the Japanese Board of Cancer Therapy #09100064 Present Position or Academic Rank 2008-present Assistant Professor, Gastroenterology, Tokyo University School of Medicine 2011-present Assistant Professor, Gastroenterology Kagawa University School of Medicine 2016-present Professor Gastroenterology, Teikyo University School of Medicine Chiba Medical Center Previous Professional Positions and Appointments 1995-1998 Staff Physician, Internal Medicine (II), Tokyo University School of Medicine, Tokyo, Japan 1998-2002 Staff Physician, Gastroenterology, Tokyo University School of Medicine 2002-2016 Division Chief, Department of Internal Medicine, Division of Hepatology, Kyoundo Hospital 2005-2016 Director, Sasaki Foundation 2006-2016 Director, Kyoundo Hospital, Tokyo, Japan 2009-2016 Assistant Professor in Gastroenterology Teikyo University School of Medicine 2012-2015 Assistant Professor, Gastroenterology Yamanasi University School of Medicine Honors and Awards 2009 Fellowship Award from the Foundation for Promotion of Cancer Research Professional and Society Membership 1991-present The Japanese Society of Internal Medicine 1993-present The Japanese Society of Gastroenterology 1993-present The Japanese Society of Hepatology 2007-present The Asian Pacific Association of the Study of the Liver |
|
Dr. Sadahisa OgasawaraAssistant Professor, Clinical Research Center, Chiba University Hospital |
|
 |
Education: 1998-2004 Chiba University School of Medicine, Chiba, Japan Present Appointments: ・Assistant professor, Clinical Research Center, Chiba University Hospital ・Staff, Department of Gastroenterology and Nephrology, Chiba University |
|
Appointments: 2004 Apr -2005 Mar Resident, Chiba University Hospital 2005 Apr -2006 Mar Resident, Kimitsu Central Hospital 2006 Apr -2006 Oct Staff, Department of Gastroenterology and Nephrology,Chiba University 2006 Oct - 2007 Sep Staff, Chiba Cerebral and Cardiovascular Center 2007 Oct -2009 Mar Staff, Kimitsu Central Hospital 2009 Apr - Present Staff, Department of Gastroenterology and Nephrology,Chiba University 2013 Nov -2016 Mar Assistant professor, Department of Medicine and Clinical Oncology, Graduate School of Medicine, Chiba University 2016 Apr -Present Assistant professor, Clinical research center, Chiba University Hospital Medical Society Membership Japanese Society of Internal Medicine certifying physician Japanese Society of Gastroenterology Japan Society of Hepatology Japanese Society of Medical Oncology Japanese Society of Clinical Oncology American Society of Clinical Oncology European Association for the Study of the Liver |
|
Dr. Masatsune OguraChief Scientist, Division of Lipid metabolism, Department of Molecular Innovation in Lipidology, National Cerebral and Cardiovascular Center Research Institute |
|
 |
Simplified CV 1998 M.D., National Defense Medical College 2009 Ph.D., Graduate School, National Defense Medical College 2011 Assistant Professor, Division of Anti-aging and Vascular Medicine, Department of Internal Medicine, National Defense Medical College |
|
2013 Senior Researcher, Department of Molecular Innovation in Lipidology, National Cerebral and Cardiovascular Center Research Institute 2016 Chief Scientist, Division of Lipid metabolism, Department of Molecular Innovation in Lipidology, National Cerebral and Cardiovascular Center Research Institute Area of Expertise Lipid metabolism, familial hypercholesterolemia, HDL functionality Professional Affiliations and Memberships Fellow of the Japanese Society of Internal Medicine Board Certified Member of Japanese Society of Internal Medicine Board Certified Member of Japanese Circulation Society Board Certified Member of Japanese Society of Atherosclerosis Council Board Member for Japanese Society of Atherosclerosis Board Certified Member of Japanese Society of Geriatrics Council Board Member for Japan Transporter Research Association Expert Member of Japan Society of Clinical Chemistry Member of European Atherosclerosis Society Professional Member of European Society of Cardiology Editorial Board Member, Journal of Atherosclerosis and Thrombosis Award 2011 Incentive Award, Young Investigator Award in Japanese Society of Atherosclerosis |
|
Dr. Masao OmataPresident, Yamanashi Prefectural Central Hospital |
|
 |
Masao Omata, MD, has made an effort to revitalize the APASL (Asian Pacific Association for the Study of the Liver) with Dr. S. Sarin and others for the last 10 years. He is a Co-Editor in Chief of the Hepatology International, an official journal of APASL. He graduated from Chiba University School of Medicine (Dr. Okuda), and continued his training at Yale University (Dr. G. Klaskin) and in the Liver Unit at University of Southern California (Dr. R.L. Peters). After 6 years in US, he returned to the Department of Medicine at Chiba University in 1989, and |
|
started molecular biological study on Hepatitis B virus. In 1992, he became Chairman of Second Department of International Medicine at University of Tokyo, Japan and then subsequently became chairman of Department of Gastroenterology. Under his leadership, the Department of Gastroenterology had become one of the foremost centers in its field. Now, he is the president of the two hospitals at Yamanashi, west of Tokyo, where, although scenic place with Mt. Fuji, hepatitis virus infection is epidemic and his homeland. He and his colleague have published 1,141 articles in English Literature including, NEJM 5, Lancet 6, Ann Int Med 6, Hepatology 59, Gastroenterology 43. The total impact factor is 6,439 and 43,025 citations with H-index of 105 as of July 1, 2016. |
|
Dr. Isao SakaidaProfessor and Chairman of Gastroenterology & Hepatology, Yamaguchi University |
|
 |
Education Yamaguchi University, School of Medicine, (1978-1984) (M.D. degree) Residency Yamaguchi University Hospital (1984-1987) |
|
Fellowship Department of Pathology, Thomas Jefferson University, Philadelphia PA (1987-1990) Academic Appointments 1990-1993: Registar of First Department of Internal Medicine, Yamaguchi University, School of Medicine 1993-2002: Assistant Professor of First Department of Internal Medicine, Yamaguchi University 2002-2003: Lecturer of Department of Gastroenterology & Hepatology, Yamaguchi University 2004: Associate Professor of Gastroenterology & Hepatology 2005-Present: Professor and Chairman of Gastroenterology & Hepatology, Yamaguchi University 2012-2016: Dean of Faculty of Medicine Yamaguchi University 2014-: Visiting Professor of Imperial College of London (UK) 2016-: Director of regenerative medicine & cell therapy Selected Papers (reviewed papers 313)
|
|
Dr. Yutaka SasakiProfessor & Chairman, Department of Gastroenterology |
|
 |
Education: 1979 M.D. Osaka University School of Medicine 1989 Ph.D. (Dr. of Medical Science) Osaka University School of Medicine (Thesis Title: Cellular analysis of c-Ha-ras gene expression in rat liver after CCI 4 administration) |
|
Academic appointments: 1990,11-1997,9 Assistant Professor, First Department of Medicine, Osaka University School of Medicine 1991,1-1992,1 Visiting Scientist, Department of Pharmacology, School of Medicine, University of California, San Diego 1992,2-1993,9 Visiting Scientist, Molecular Hepatology Laboratory, MGH Cancer Center, Massachusetts General Hospital, Harvard Medical School, Charlestown 1997,10-1999,3 Associate Professor, First Department of Medicine, Osaka University School of Medicine 1999,4-2005,1 Associate Professor, Molecular Therapeutics, Graduate School of Medicine, Osaka University 2005,1-2005,3 Professor & Chairman, First Department of Internal Medicine, Kumamoto University School of Medicine 2005,4-present Professor & Chairman, Department of Gastroenterology Hepatology, Graduate School of Medical Sciences, Kumamoto University Hospital Appointments: 1979,7 -1980, 6 Resident in First Department of Medicine, Osaka University Hospital 1980, 7-1982, 7 Medical Staff in Internal Medicine, Osaka Kosei Nenkin Hospital 1982, 8-1990, 10 Senior Staff, First Department of Medicine, First Department of Medicine, Osaka University Hospital 1990, 11-1999, 3 Fellow, First Department of Medicine, Osaka University Hospital 1999, 4- 2005, 1 Division Chief, Department of Gastroenterology, Osaka University Hospital 2005, 1-2005, 3 Director, First Department of Medicine, Kumamoto University Hospital 2005, 4-present Director, Department of Gastroenterology, Kumamoto University Hospital Director, Endoscopy Center, Kumamoto University Hospital Professional Societies: Japanese Society of Hepatology (JSH) Director (2010, 5 - present) Chair, Board Certification Committee (2010, 5 - present) The president of the 51th Annual Meeting of JSH (2015, 5 Kumamoto, JAPAN) Japanese Society of Gastroenterology (JSG) Director (2015, 4 - present) Chair, Postgraduate Education Committee (2015, 4 - present) Chair, Publication Committee of Journal of JSG (2009, 4 - 2015, 3) The president of 108th Kyushu Regional Meeting of JSG (2016, 11 Kumamoto, JAPAN) Japanese Society of Internal Medicine Councilor Japanese Society of Portal Hypertension (JSPH) Director The president of the annual meeting of JSPH (2017, Osaka, JAPAN) Japanese Society of Gastroenterological Endoscopy Councilor Japanese Cancer Association Member American Association of Study of Liver Disease Member |
|
Dr. Naoya SakamotoProfessor/Chairman, Dept. of Gastroenterology and Hepatology |
|
 |
Prof. Naoya Sakamoto received his M.D. and Ph.D. degrees from School of Medicine, Tokyo Medical and Dental University in 1987 and 1994, respectively. He then worked as a lecturer, associate professor at Dept. of Gastroenterology and Hepatology, Tokyo Medical and Dental University. He spent 3 years as a research fellow at Division of Gastroenterology-Hepatology, University of Connecticut Health Center, CT, USA. He was then promoted as a professor/chairman at Dept. of Gastroenterology and Hepatology, |
| Hokkaido University Graduate School of Medicine in 2012. His Areas of Expertise are Molecular biology of hepatitis viruses: HCV, HBV, HAV and HEV, and basic and clinical development of antiviral regimens against HCV and HBV. He is the vice editor in chief of the Journal of Gastroenterology, an associate editor of the Hepatology Research, and an editorial board member of the Journal of Gastroenterology and Hepatology, Antimicrobial Agents and Chemotherapy an Hepatology International. He is a director of the Japan Society of Hepatology, committee member of the Japanese Society of Gastroenterology and Japanese Society of Internal Medicine, and an International Member of the American Association for the Study of Liver Diseases and the American Society of Microbiology. | |
Dr. Shotaro SakisakaProfessor and Chairman of Gastroenterology and Medicine, Fukuoka University |
|
 |
Prof. Sakisaka was graduated in 1978 and worked with Prof. K. Tanikawa in Kurume Univ. Then, he moved to Yale Univ. to work with Prof. James Boyer from 1985 to 1987. After he worked in Kurume Univ., he moved to Fukuoka University in 2000. He has been interested in viral hepatitis, HCC, PBC, and liver transplantation. His team has already achieved more than 2000 RFA for HCC patients with outstanding survival. |
Dr. Shinji ShimodaAssociate professor, Dept. of Medicine and Biosystemic Science, Faculty of Medicine, Kyushu University |
|
 |
Associate Professor Shinji Shimoda was graduated with M.D. in 1989 from Kyushu University, Japan. Dr. Shimoda spent two and half years as a research fellow under the instruction of professor M Eric Gershwin at University of California Davis from 1995 to 1998. He obtained his Ph.D. degree from Kyushu University in 1996. His research interests are clinical immunology (particularly liver immunology), and he has a long-term research interest in autoimmunity |
| and infection immunity. He is a reviewer and member of editorial board of several scientific journals (Hepatology Research, Journal of Autoimmunity, World Journal of Gastroenterology). He has published 20 book chapters, and over 120 original and review articles in international journals, whose total impact factors are more than 600. He has received numerous awards including the research encouragement award in 1996 and the CHUGAI Award in 2012 from the Japan Society of Hepatology. | |
Dr. Koichi ShiraishiProfessor of Department of Gastroenterology, Tokai University School of Medicine |
|
 |
Univ. Graduated: Tokai University School of Medicine March 1984 Doctor of Medical Science: March 1993 “Impaired erythrocyte deformability and membrane fluidity in alcoholic liver disease: participation in disturbed hepatic microcirculation” Current Appointment: April 2015 to present: Tokai University School of Medicine Oiso Hospital |
|
Department of Gastroenterology Professor April 2002 to present: Tokai University School of Medicine Department of Gastroenterology Associate Professor April 2007 to March 2010: Assistant Senior Executive Director of Tokai University Hachioji Hospital Education and Training: June 1984 to May 1986: Resident of Internal Medicine Kawasaki Municipal Hospital June 1986 to March 1989: Senior Resident of Gastroenterology Tokai University School of Medicine Professional Experience: April 1989 to March 1994: Assistant of Department of Gastroenterology Tokai University School of Medicine April 1994 to March 2002: Assistant Professor of Department of Gastroenterology Tokai University School of Medicine April 2002 to Present: Associate Professor of Department of Gastroenterology Tokai University School of Medicine April 2015 to present: Professor of Department of Gastroenterology Tokai University School of Medicine |
|
Dr. Fumitaka SuzukiDirector, Department of Hepatology, Federation of National Public Service Personnel Mutual Aid Associations, Toranomon Hospital |
|
 |
1988：Graduated from Hirosaki University School of Medicine, Japan 1988-1989：(Post-graduate Training) Second Division of Internal Medicine, Hamamatsu University School of Medicine 1989-1993：Department of Gastroentelorogy, Hamamatsu Medical Center 1993-1994：Department of Hepatology, Toranomon Hospital 1994-1998：Second Division of Internal Medicine, Hamamatsu University School of Medicine |
|
1998-1999：Department of Gastroentelorogy, Hamamatsu Medical Center 1999-：Department of Hepatology, Toranomon Hospital 2011-：Director, Department of Hepatology, Toranomon Hospital Research Interest; Viral hepatitis, Anti-viral treatment |
|
Dr. Tetsuo TakeharaProfessor of Medicine, Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine |
|
 |
Dr. Tetsuo Takehara is a Professor of Medicine in the Department of Gastroenterology and Hepatology at Osaka University Graduate School of Medicine Japan. He graduated from Osaka University Medical School in 1984 and received clinical training in internal medicine and gastroenterology at Osaka University Hospital and its affiliated hospitals for several years. He obtained his Ph.D. in Medicine at Osaka University in 1993, and went on to study as a postdoctoral fellow at the Massachusetts General Hospital/Harvard |
|
Medical School, Division of Gastroenterology, Boston, MA, from 1998 to 2000. Dr. Takehara is a physician scientist in hepatology and gastroenterology and his major research interests include, basic research on cell death and innate immunity and, clinically, viral and non-viral hepatitis, and hepatocellular carcinoma (HCC). Currently, he studies the mechanistic links between hepatocyte apoptosis/autophagy and the progression of liver disease to fibrosis and cancer. He also studies HBV/HCV virology and anti-viral strategies using a sophisticated mouse model with a humanized liver. He directs and oversees the Osaka Liver Forum (OLF) study, a large and comprehensive cohort study of hepatitis B/C and HCC patients at Osaka University Hospital and more than 30 of its affiliated hospitals in the Kansai area. For example, the OLF study includes more than 5,000 patients being treated with pegylated interferon and ribavirin and more than 1,500 patients treated with direct-acting antiviral combination therapies. His work has demonstrated a wide range of clinical evidence among this cohort for the management of patients with viral hepatitis and HCC. He has published more than 300 basic science and clinical articles in high-quality journals. Currently, Dr. Takehara is the director of the Japan Society of Hepatology and has been the Editor-in Chief of Hepatology Research since 2014. |
|
Dr. Atsushi TanakaProfessor, Department of Medicine, Teikyo University School of Medicine |
|
 |
Prof. Atsushi Tanaka was graduated with M.D. degree in 1988 from the University of Tokyo, Japan. After spending three years as residency at St. Luke’s International Hospital in Tokyo, he started his career as a researcher in liver diseases with a main focus on autoimmune liver diseases and viral hepatitis. He obtained his Ph.D. degree from the University of Tokyo in 1996, and thereafter he stayed at the University of California, Davis since 1996 to 1999 as a visiting scholar with M. Eric Gershwin, M.D., where he elucidated T cell mechanisms |
|
involved in the pathogenesis and progression of primary biliary cholangitis (PBC). Coming back to Japan in 2000, he rose through the academic ranks to become a Professor of Medicine at the Teikyo University School of Medicine in 2011. His area of expertise is autoimmune liver diseases, especially PBC, PSC and AIH. He has authored 100 peer-reviewed manuscripts devoted to these topics. In addition, he was Co-Director (along with Prof. Xiong Ma from China) of the first APASL satellite symposium on the epidemiology and treatment of AIH and PBC in the Asian-Pacific region, which was held during the 2016 APASL meeting. He has provided exceptional leadership to Japanese hepatology, including ongoing service as Secretary-General of the Drafting Committee for Hepatitis Management Guidelines of the Japan Society of Hepatology (JSH) and play a central role in publishing as well as revising the JSH Guidelines for the Management of HBV/HCV infection. Currently he also serves as a Secretary-General of the Intractable Hepatobiliary Disease Study Group supported by the Ministry of Health, Labor and Welfare of Japan, and is one of the leaders for research of autoimmune liver diseases in Japan. |
|
Dr. Eiji TanakaProfessor, Department of Medicine, Shinshu University School of Medicine |
|
 |
Education and Experience 1/16/2008-present: Professor, Department of Medicine, Shinshu University School of Medicine 6/1/2001-1/15/2008: Associated Professor, Department of Medicine, Shinshu University School of Medicine 11/1/1995-5/31/2001: Lecturer, Department of Medicine, Shinshu University School of Medicine |
|
2/1/1988-10/30/1995: Assistant Professor, Department of Medicine, Shinshu University School of Medicine 10/1/1987-1/31/1988: Post-doctoral fellow, Department of Medicine, Shinshu University School of Medicine 7/1/1986-9/30/1987: Nagano Prefectural Kiso Hospital 10/1/1985-6/30/1986: Post doctoral fellow, Department of Medicine, Shinshu University School of Medicine 1/1/1985-9/30/1985: Aizawa Hospital 7/1/1982-12/31/1984: Assistant Professor, Immunology Division, Jichi Medical School 4/1/1978-6/30/1982: Post-graduate school of Shinshu University School of Medicine 3/25/1978: Graduated from School of Medicine, Kanazawa University Study Abroad 10/1/1995-3/31/1996: Department of Transfusion Medicine, National Institutes of Health Degree 5/27/78: Medical Doctor #240077 6/30/82: Ph.D., Shinshu University #201 Main Study Field Liver diseases especially viral hepatitis |
|
Dr. Junko TanakaProfessor and Chaiman, Dept. of Epidemiology, Infectious Disease Control and Prevention, Institute of Biomedical and Health Sciences, Hiroshima University |
|
 |
Education 1980：B.Sc (Mathematics) , Ochanomizu University, Tokyo 1989：Ph.D., Department of Hygiene, Hiroshima University Graduate School of Medical Sciences Research and Professional Experience: |
|
2014-present：Chair, School of Medicine, Hiroshima University. 2015-present：Chief of course, MPH(Master of Public Health) course in Institute of Biomedical and Health Sciences, Hiroshima University 2012-present：Director, Project Research Center for epidemiology and prevention of viral hepatitis and hepatocellular carcinoma, Hiroshima University 2009-present：Professor and Chaiman, Dept. of Epidemiology, Infectious Disease Control and Prevention, Institute of Biomedical and Health Sciences, Hiroshima University 2004-2009: Associate Professor, Dept. of Epidemiology, Infectious Disease Control and Prevention, Hiroshima University Graduate School of Biomedical Sciences 1981-1987, 1990-1995,：Assistant Professor, 1995-2004 Senior Lecturer Dept. of Epidemiology, Infectious Disease Control and Prevention(Dept. of Hygiene), Hiroshima University Graduate School of Biomedical Sciences 1991：Visiting Associate Professor, Dept. of Public Health, Division of Biostatistics, University of Minnesota, USA Chairman, Health and Labour Science Research Grants, Ministry of Health, Labour and Welfare, Japan (Research on Epidemiology of hepatitis virus infection and its long term prognosis (since 2008) Special Fields: Hygiene/Public health, Epidemiology, Biostatistics, Theoretical epidemiology Epidemiology of Viral Hepatitis |
|
Dr. Yasuhito TanakaProfessor and Director, Virology & Liver Unit |
|
 |
Prof. Yasuhito Tanaka received Degree of M.D in1991 from Nagoya City University, and worked as a resident in Nagoya City University Hospital, Clinical staff at Division of Gastroenterology, Nagoya Daini Red Cross Hospital: 1993-1997 He studied at NIH in USA from 1999 to 2001,under Dr. Alter, who was awarded the Lasker Prize in praise of the discovery of HCV, and proved Japanese people were infected HCV 30 years earlier than Americans(Proc Natl Acad Sci USA,2002) |
|
Assistant professor at Department of Clinical Molecular Informative Medicine, Nagoya City University Graduate School of Medical Sciences in 2001, and later became lecture and Associate Professor. In 2009, he identified “hereditary factor that defines interferon treatment effectiveness against chronic hepatitis C (IL28B SNPs)” which appeared in Nature Genetics. 2009-present, Professor and Director, Department of Virology & Liver unit, Nagoya City University Graduate School of Medical Sciences. Sub Director, Liver Disease Unit,Director,Central Clinical Laboratory, Nagoya City University Hospital .Since 2010, he is a representative for two AMED projects related with hepatitis B and C viruses. |
|
Dr. Takuji TorimuraProfessor, |
|
 |
Dr. Takuji Torimura is currently a professor of Department of Medicine, Division of Gastroenterology, Kurume University School of Medicine since 2014. He graduated from Kurume University School of Medicine in 1982. He completed a clinical fellowship in Kurume University Hospital followed by a research fellowship at Second Department of Medicine, Kurume University School of Medicine, where he received his M.D. degree in Medical Science in 1990. He was nominated as a professor at Research Center for Innovative |
|
Cancer Therapy in 2011. He became a vice-president of Kurume university hospital in 2016. He is a member of The Japanese Society of internal Medicine, The Japanese Society of Gastroenterology, The Japanese Society of Hepatology, The Japanese Cancer Association, Japan Gastroenterological Endoscopy Society, American Association for the Study of Liver Diseases and American Association of Cancer Research. His research interests have focused on mechanism of angiogenesis and antiangiogenic therapy for hepatocellular carcinoma. Recently, he is also interested in hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma. |
|
Dr. Yoshiyuki UenoProfessor of Medicine, Head of Division of Gastroenterology and Hepatology and Vice Director of Yamagata University Hospital |
|
 |
Professor Yoshiyuki Ueno is currently Professor of Medicine, Head of Division of Gastroenterology and Hepatology and Vice Director of Yamagata University Hospital. He is the course director of PhD course in Gastroenterology, Postgraduate School of Medicine Yamagata University. Professor Ueno has been engaged in the field of Hepatology since after his graduation of medical school at Tohoku University in 1987. After obtaining PhD degree in 1991, he had been a research fellow at Mayo Clinic, Rochester, USA. Since after his return to |
| Japan, he continues to work as an academic researcher. Currently, he is an associate editor of Hepatology Research, Hepatology International, and Seminars in Liver Diseases. He has been actively involved in more than 20 international trials on antiviral treatment of chronic hepatitis B and C. He is one of the AASLD inaugural Fellow, and first Japanese hepatologist to become both AASLD and AGA Fellow. He has been involved in several steering committees of academic societies. He has received numerous local, national and international research awards. He has published more than 250 peer-reviewed papers in international journals including 2 in PNAS, 9 in Gastroenterology, 22 in Hepatology, 3 in J Hepatol, 22 in AJP. | |
Dr. Takaji WakitaDeputy Director General, National Institute of Infectious Diseases |
|
 |
Takaji Wakita received his medical degree in 1983 from Nagoya University, Nagoya, Japan. He was then trained in the clinic for 5 years. He obtained his PhD in Internal Medicine III at Nagoya University in 1992 for a thesis entitled "Detection of pre-C and core region mutants of hepatitis B virus in chronic hepatitis B carriers". He received postdoctoral training at Molecular Hepatology Laboratory (Dr. Jack Wands' Lab), Massachusetts General Hospital Cancer Center, Boston between 1992 and 1995, work commenced on antisense |
| inhibition of hepatitis C virus. In 1995, he moved to Department of Microbiology, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan, and then moved to Tokyo Metropolitan Institute for Neuroscience as a Principal Investigator in 1998. In 2006, he moved to National Institute of Infectious Diseases, Tokyo, Japan, and was appointed as a Director of Department of Virology II. In 2015, he was appointed as a Deputy Director-General of National Institute of Infectious Diseases. His major research interests include; Infection and replication models of hepatitis C virus, Pathogenesis of hepatitis viruses, and Novel therapeutics and vaccine development for hepatitis virus infections. He received Hideyo Noguchi Memorial Medical Award in 2008, and Oda Prize (awarded by the Japanese Society of Hepatology) in 2009. | |
Dr. Osamu YokosukaPresident, Japan Community Health Care Organization (JCHO) Funabashi Central Hospital |
|
 |
1975: Graduated Chiba University School of Medicine 1975-1978: Trainee in Chiba University Hospital (Prof. K Okuda) 1978-1980: Royal Free Hospital, London (Prof. S Schelock, Prof. BH Billing) 1980-1985: Fellow (Chiba University) 1984: Fox Chase Cancer Center, Philadelphia (Dr. J Summers) 1985: Degree of Dr. of Medical Science 1985-1994: Assistant Professor, Chiba University |
|
1994-2006: Lecturer in Medicine, Chiba University 2006-2016: Director and Professor of Medicine, Chiba University 2008-2014: Secretary General of APASL 2013-2015: Dean, Chiba University School of Medicine 2015-2016 : President of APASL 2016 Tokyo 2016 - : President, Japan Community Health Care Organization (JCHO) Funabashi Central Hospital Main field of interest Hepatitis and Hepatocellular Carcinoma |
|
Dr. Hitoshi YoshijiChairman and Professor of Third Department of Internal Medicine (Gastroenterology and Hepatology) at Nara Medical University |
|
 |
Hitoshi Yoshiji is Chairman and Professor of Third Department of Internal Medicine (Gastroenterology and Hepatology) at Nara Medical University. He graduated in medicine from Nara Medical University in 1987. He got Ph. D (Medical Science) from the graduate school of medicine Nara Medical University in 1993. His thesis is Oxidative Stress in Liver Carcinogenesis. From 1994 to 1997, he worked in NIH, National Cancer Institute, USA as a visiting fellow with Dr. Thorgeirsson. From 2015, he works as Chairman and Professor of Third |
| Department of Internal Medicine (Gastroenterology and Hepatology) at Nara Medical University. He is a councilor of many academic societies, such as The Japanese Society of Gastroenterology, The Japanese Society of Hepatology, and The Japanese Society of Internal Medicine. Since he is also a clinician, he is a certified doctor of several fields; Japanese Society of Internal Medicine, Japanese Society of Gastroenterology, Japanese Society of Hepatology, and Japanese Gastroenterological Endoscopy Society. He also contributes international academic societies, Founding member of ILCA (International Liver Cancer Association), Active member of American Association of Cancer Research Active member of New York Academy of Science. He also contributes many international peer-reviewed scientific journals; Associate Editor-in Chief: World Journal of Gastroenterology. Total Editorial Board of 14 Foreign Journals, such as Hepatology Research, Experimental and Therapeutic Medicine, and World Journal of Hepatology. He got many awards such as UICC (International union against cancer) Young investigator award, Award of Japanese Society of Hepatology, and Award of Japanese Hepatology Research. He has published more than two hundred articles in international peer-reviewed high citation journals. Total impact factor of Thomson Reuters is more than seven hundred fifty. He has many high-index articles. According to Thomson Reuters, he ranks among the top 1% of most cited Japanese researcher cited in Pub Med Central in 1993. | |
Dr. Kentaro YoshiokaProfessor, Department of Liver, Biliary Tract and Pancreas Diseases, Fujita Health University, Toyoake, Japan |
|
 |
EMPLOYMENT 1979-1982, Physician, Nagoya First Red Cross Hospital 1982-1984, GI Fellow, Department of Internal Medicine, Nagoya University School of Medicine 1984-1986, Research Fellow, Department of Internal Medicine, University of Medicine and Dentistry of New Jersey |
|
1986-1987, Physician, Clinic of Nagoya Courthouse 1987-1998, Assistant, Department of Internal Medicine, Nagoya University School of Medicine 1998-2004, Assistant Professor, Department of Internal Medicine, Nagoya University School of Medicine 2004-2005, Associate Professor, Department of Liver, Biliary Tract and Pancreas Diseases, Fujita Health University 2005-Present, Professor, Department of Liver, Biliary Tract and Pancreas Diseases, Fujita Health University EDUCATION 1979, MD, Nagoya University School of Medicine 1987, PhD, Nagoya University School of Medicine HONORS 1991, Research Encouragement Prize of Japanese Association of Study of Liver Diseases 2012, High Citation Award of Japanese Association of Study of Liver Diseases PUBLICATION Professor Yoshioka’s main research interests include the natural history, molecular virology, pathogenesis and treatment of chronic viral hepatitis and HCC. He has published more than 150 articles in both national and international journals, including Hepatology, Gastroenterology, and Hepatology research. |
|
Dr. Hiroshi YotsuyanagiAssociate Professor, Chief of the Department |
|
 |
Education 1980/1986: the University of Tokyo Undergraduate Program Post Graduate Training 1986/1998: the University of Tokyo Postgraduate Program 1998/1990: Toshiba General Hospital Gastroenterology Program |
|
Certifications 1995: M.D. (molecular virology of hepatitis A virus) Professional Appointments 1995: Assistant Professor (the University of Tokyo Hospital) 1998: Associate Professor (St. Marianna University School of Medicine) 2004: Associate Professor (the University of Tokyo Hospital, Dept. of Infection Control and Prevention) 2008: Associate Professor (the University of Tokyo, Dept. of Infectious Diseases) 2010: Chief of the Department. |
|
Local Committee
Dr. Hiroshi YatsuhashiDirector General, Clinical Research Center, National Hospital Organization(NHO) Nagasaki Medical Center |
|
 |
1984: Graduated from Nagasaki University School of Medicine 1984-1988:（Post-graduate Training） 1st Department of Medicine, Nagasaki University 1988-: Clinical Research Center, Nagasaki Medical Center 2002-2012: Director, Department of Therapeutic Research, Clinical Research Center, Nagasaki Medical Center |
| 2004-: Professor, Division of Viral Hepatitis, Department of Hepatology, Nagasaki University Graduate School of Biomedical Sciences, 2012-: Director General, Clinical Research Center, Nagasaki Medical Center 2013-: APASL Executive Council Research Interest Viral hepatitis, Anti-viral treatment, Hepatocellular Carcinoma (HCC), Risk factors for development of HCC |
|
Dr. Shuichiro ShiinaProfessor, Department of Gastroenterology, Juntendo University |
|
 |
Shuichiro Shiina graduated in Medicine at the University of Tokyo in 1982. He completed a residency and fellowship training at the University of Tokyo Hospital and Mitsui Memorial Hospital. He received Ph.D. degree in Medical Science with a study “A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma” at the University of Tokyo in 2005. He moved to Juntendo University in December 2012. |
|
Dr. Shiina has been a pioneer of image-guided percutaneous ablation therapies for liver tumors, such as percutaneous ethanol injection, microwave ablation, and radiofrequency ablation. He has performed radiofrequency ablation on over 10,000 patients with liver tumors. Dr. Shiina published over 200 international scientific papers in high quality English Journal and over 300 domestic scientific papers. He is a member of The American Gastroenterological Association, Asian Pacific Association for the Study of the Liver, The International Liver Cancer Association, The Japanese Society of Internal Medicine, The Japanese Society of Gastroenterology, The Japan Society of Hepatology, The Japan Society of Ultrasonics in Medicine, The Liver Cancer Study Group of Japan, Study Group of Microwave Surgery, The Japan Society of Clinical Oncology, The Japan Pancreas Society, and Japanese Society of Interventional Radiology, and others. His research interests are “Interventional Oncology, such as Radiofrequency Ablation”, “Diagnosis and Treatment of Liver Neoplasms”, and “Chemotherapy of GI tract and Liver Cancers”. ● Shiina S, et al. Percutaneous ethanol injection therapy for hepatocellular carcinoma. A histopathologic study. Cancer 1991;68:1524-30. ● Shiina S, et al. Percutaneous ethanol injection therapy for hepatocellular carcinoma: results in 146 patients. AJR Am J Roentgenol 1993;160:1023-8. ● Shiina S, et al. A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology 2005;129:122-30. ● Shiina S, et al. Radiofrequency ablation for hepatocellular carcinoma: 10-year outcome and prognostic factors. Am J Gastroenterol 2012;107:569-77. ● Shiina S, et al. Percutaneous ethanol injection for hepatocellular carcinoma: 20-year outcome and prognostic factors. Liver International 2012;32:1434-42. |
|
Dr. Kazuhiko NakaoProfessor, Department of Gastroenterology and Hepatology, Nagasaki University Graduate School of Biomedical Sciences |
|
 |
Education 1983 Graduated from Nagasaki University, School of Medicine 1991 Ph. D. of Medical Science from Nagasaki University Appointments 1983-1984 Trainee, First Department of Internal Medicine, Nagasaki University School of Medicine |
| 1984-1985 Trainee, Department of Internal Medicine, Nagasaki Municipal Hospital 1985-1986 Department of Internal Medicine, Tagawa Municipal Hospital 1986-1987 Department of Medicine, National Hospital Organization Saga National Hospital 1987 Medical Staff, Department of First Internal Medicine, Nagasaki University School of Medicine 1987-1990 Researcher, Department of Biochemistry, Calgary University of Medicine, Canada 1990-1992 Researcher, Department of First Internal Medicine, Nagasaki University of Medicine 1992-1994 Vice Chair, Department of Internal Medicine, The Japanese Red Cross Nagasaki Genbaku Hospital 1994-1998 Assistant, Department of First Internal Medicine, Nagasaki University of Medicine 1998-2002 Lecturer, Nagasaki University Health Center 2002-2006 Assistant Professor, Nagasaki University Health Center 2006-2009 Assistant Professor, Department of Gastroenterology and Hepatology, Nagasaki University Graduate School of Biomedical Sciences 2009- Professor, Department of Gastroenterology and Hepatology, Nagasaki University Graduate School of Biomedical Sciences 2015- Vice Director, Nagasaki University Hospital |
|
Dr. Naoya KatoDivision of Advanced Genome Medicine, The Institute of Medical Science, The University of Tokyo |
||
 |
Education March, 1986 |
Graduated from Chiba University School of Medicine |
| Degree March, 1995 |
Doctor of Medical Sciences from Chiba University School of Medicine |
|
|
Research Carrier 1989-1992：Research fellow at First Department of Internal Medicine, Chiba University School of Medicine 1992-1993：Research fellow at Virology Division, National Cancer Center Research Institute 1993-1998：Research fellow at Department of Gastroenterology, Faculty of Medicine, The University of Tokyo 1999-2008：Research associate at Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo 2008. Jan-Nov：Project lecturer at Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo 2008. Dec-2013. March： Project associate professor and Director at Unit of Disease Control Genome Medicine, The Institute of Medical Science, The University of Tokyo 2013. April-：Associate professor and Director at Division of Advanced Genome Medicine, The Institute of Medical Science, The University of Tokyo Specialty Hepatitis B, Hepatitis C, Hepatocellular carcinoma |
||
Dr. Atsumasa KomoriDirector, Department of Treatment for Intractable Disease in Clinical Research Center, |
|
 |
Atsumasa Komori is a staff hepatologist, and the Director of Department of Treatment for Intractable Disease in Clinical Research Center, National Hospital Organization Nagasaki Medical Center, Japan. After graduation of Kyushu University School of Medicine, followed by the training in the field of cancer research at National Cancer Center/Saitama Cancer Center and of basic immunology at Weill Medical School of Cornell University, USA, his research |
| interest is now focused to autoimmune liver diseases, as well as to hepatocarcinogenesis. He is also the chief of Division of International Medical Cooperation in Nagasaki Medical Center, whose recent clinical activity in the Republic of Kazakhstan was awarded as an honorary professor of Kazakhstan National Medical University. He is a board certified hepatologist and member of the board of trustees of the Japan Society of Hepatology. | |